The EldeLumab Biosimilar Anti-CXCL10 Antibody is a cutting-edge product designed for researchers studying CXCL10, a chemokine involved in inflammation and immune responses. This antibody, produced through biosimilar technology, has high specificity and sensitivity for detecting the CXCL10 protein in human samples. Validated for use in various applications, including ELISA and immunohistochemistry, it allows for precise analysis and visualization of CXCL10 expression in different biological samples.CXCL10, also known as interferon gamma-induced protein 10 (IP-10), plays a crucial role in recruiting immune cells to sites of inflammation and infection. Its dysregulation has been implicated in various diseases, including autoimmune disorders, viral infections, and cancer.
By targeting CXCL10, researchers aim to better understand its role in disease pathogenesis and potentially develop new therapeutic strategies to modulate immune responses and inflammation.With its advanced technology and proven effectiveness, the EldeLumab Biosimilar Anti-CXCL10 Antibody is a valuable tool for researchers in immunology, oncology, and infectious diseases. By accurately detecting and quantifying CXCL10 levels, this antibody offers new insights into the complex mechanisms of immune regulation and provides opportunities for developing targeted therapies in the future.
Product Name:
Eldelumab (Anti-CXCL10) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0118
Target:
CXCL10
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
BMS-936557, MDX-1100
Description:
Anti-CXCL10(eldelumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
